REQUEST A DEMO
Total
USD $0.00
Search more companies

Hl Pharmaceuticals Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Hl Pharmaceuticals Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Hl Pharmaceuticals Sdn. Bhd. is an enterprise based in Malaysia. Its main office is in Kuala Lumpur. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on July 31, 2012. From the latest financial highlights, Hl Pharmaceuticals Sdn. Bhd. reported a net sales revenue increase of 12.48% in 2023. Over the same period, its total assets grew by 18.76%. In 2023, Hl Pharmaceuticals Sdn. Bhd.’s net profit margin increased by 2.73%.

Headquarters
3A, No. 760 & 762, Jalan Sentul
Kuala Lumpur; Federal Territories; Postal Code: 51000

Contact Details: Purchase the Hl Pharmaceuticals Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Hl Pharmaceuticals Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Hl Pharmaceuticals Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Hl Pharmaceuticals Sdn. Bhd. report to view the information.
Incorporation Date:
July 31, 2012
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
52.65%
Purchase this report to view the information.
3.5%
Purchase this report to view the information.
3.3%
Purchase this report to view the information.
3.3%
Purchase this report to view the information.
3.3%
Company Performance
Financial values in the chart are available after Hl Pharmaceuticals Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
12.48%
Total operating revenue
12.48%
Operating profit (EBIT)
25.85%
EBITDA
25.87%
Net Profit (Loss) for the Period
25.96%
Total assets
18.76%
Total equity
41.09%
Operating Profit Margin (ROS)
3.55%
Net Profit Margin
2.73%
Return on Equity (ROE)
-3.66%
Quick Ratio
16.43%
Cash Ratio
1.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?